Submitted by Anonymous (not verified) on 14 October 2026 - 8:05
Human medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Date of authorisation: 28/08/2026, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Date of authorisation: 28/08/2026, Status: Authorised